4/4/2013

The Bill & Melinda Gates Foundation, through its Grand Challenges Explorations initiative, awarded Tetragenetics a Phase II grant worth $826,000 to develop a more effective oral vaccine for malaria. The grant builds on a 2009 Phase I grant.

Related Summaries